Outcome and death risk of diabetes patients with Covid-19 receiving pre-hospital and in-hospital metformin therapies.

Tamura, Rodrigo Esaki; Said, Said Muhammad; de Freitas, Leticia Mussin; Rubio, Ileana Gabriela Sanchez

Tamura, Rodrigo Esaki; Said, Said Muhammad; de Freitas, Leticia Mussin; Rubio, Ileana Gabriela Sanchez.

Afiliação

Tamura RE; Department of Biological Sciences, Federal University of São Paulo, Rua Pedro de Toledo 669, 11º Andar, Diadema, SP, Brazil.
Said SM; Laboratory of Cancer Molecular Biology, Federal University of Sao Paulo, São Paulo, SP, Brazil.
de Freitas LM; Thyroid Molecular Sciences Laboratory, Federal University of Sao Paulo, São Paulo, SP, Brazil.
Rubio IGS; Santa Catarina Hospital, São Paulo, Brazil.

Diabetol Metab Syndr ; 13(1): 76, 2021 Jul 13.

Article em En | MEDLINE | ID: mdl-34256824

Palavras-chave

Brazil; COVID-19; Diabetes; Metformin; Survival

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google